South & Central America Enteral and Parenteral Medical Nutrition Market

The South & Central America enteral and parenteral medical nutrition market is expected to grow from US$ 975.68 million in 2023 to US$ 1,377.32 million by 2028. It is estimated to grow at a CAGR of 7.1% from 2023 to 2028.   

Rise in Prevalence of Gastrointestinal Diseases Fuels South & Central America Enteral and Parenteral Medical Nutrition Market

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancers are a few examples of gastrointestinal diseases. Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirement, which can be a result of the disease itself. Thus, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. Thus, the enteral and parenteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to food nutrition intake directly through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Some people may not show compatibility toward tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs due to diseases, such as cancer and chronic diseases affecting the gastrointestinal tract. This type of nutrition is the cornerstone of therapy for most patients with severe SBS. Therefore, the elevating prevalence of gastrointestinal diseases drives the growth of the enteral and parenteral medical nutrition market.

South & Central America Enteral and Parenteral Medical Nutrition Market Overview

The South & Central America enteral and parenteral medical nutrition market is segmented into Brazil, Argentina, Chile, Peru, Colombia, Mexico, and the Rest of South & Central America. South & Central America occupies a significant position in the enteral and parenteral medical nutrition market and is estimated to register a robust growth rate over the forecast period. Factors such as the growing geriatric population, rising incidence of chronic diseases, rising incidence of neurologic disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region are driving the market.

 South & Central America Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Enteral and Parenteral Medical Nutrition Strategic Insights

Strategic insights for the South & Central America Enteral and Parenteral Medical Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South & Central America Enteral and Parenteral Medical Nutrition Report Scope

South & Central America Enteral and Parenteral Medical Nutrition Regional Insights

The geographic scope of the South & Central America Enteral and Parenteral Medical Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

South & Central America Enteral and Parenteral Medical Nutrition Market Segmentation

The South & Central America enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the South & Central America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the South & Central America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on form, the South & Central America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on product type, the South & Central America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the South & Central America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on age group, the South & Central America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the South & Central America enteral and parenteral medical nutrition market is segmented into a hospital pharmacy, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on country, the South & Central America enteral and parenteral medical nutrition market is segmented into Brazil, Argentina, Chile, Peru, Colombia, Mexico, and the Rest of South & Central America. Brazil dominated the share of the South & Central America enteral and parenteral medical nutrition market in 2023.   

Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Nestle SA; and Nutricia International BV are some of the leading companies operating in the South & Central America enteral and parenteral medical nutrition market.